颅内脑膜瘤开放显微手术与立体定向放射外科治疗的成本评估
该单中心回顾性队列分析了2011年7月至2017年4月接受显微手术或立体定向放射外科治疗的268例颅内脑膜瘤患者,显微手术198例、立体定向放射外科70例。显微手术总成本中设施成本占比最大(59.7%),立体定向放射外科总成本中影像成本占比最大(98.2%)。多因素分析显示,显微手术总成本的驱动因素为住院时间和最大肿瘤大小,放射外科总成本的驱动因素为年龄。
要点
- 显微手术总成本中设施成本占比最大(59.7%),放射外科总成本中影像成本占比最大(98.2%)。
- 显微手术多因素分析中,住院时间(P=0.0001)和最大肿瘤大小(P=0.01)是总成本的驱动因素。
- 放射外科多因素分析中,年龄是总成本的驱动因素(P=0.003)。
核心结论
- 实施减少设施使用和影像检查的方案可降低总成本并改善资源利用,同时维持高质量的患者照护。
- 作者认为,针对真正处于治疗均衡状态的患者开展更多成本效果研究将为这些努力提供进一步指导。
研究设计与样本
- 单中心、回顾性队列研究,分析2011年7月至2017年4月接受颅内脑膜瘤显微手术或放射外科治疗的患者。
- 共纳入268例颅内脑膜瘤,其中198例接受显微手术,70例接受立体定向放射外科治疗。
- 使用Value Driven Outcomes数据库,分析患者和肿瘤特征、亚类成本及潜在成本驱动因素。
主要发现
- 显微手术总成本中设施成本占比最大(59.7%),立体定向放射外科总成本中影像成本占比最大(98.2%)。
- 非颅底肿瘤患者较颅底肿瘤患者肿瘤更大(3.7 ± 1.9 cm vs. 2.7 ± 1.2 cm,P = 0.0001),且更可能接受显微手术(81.7% vs. 55.2%)。
- 显微手术单因素分析提示,美国麻醉医师协会状态、住院时间、出院去向和最大肿瘤大小影响成本(P = 0.001),但多因素分析中仅住院时间(P = 0.0001)和最大肿瘤大小(P = 0.01)是总成本的驱动因素。
- 放射外科单因素分析(P = 0.001)和多因素分析(P = 0.003)中,年龄均显著影响成本。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Understanding costs of microsurgical or radiosurgical treatment of intracranial meningioma may offer direction in reducing health care costs and establishing cost-effective algorithms. We used the Value Driven Outcomes database, which identifies cost drivers and tracks changes over time, to evaluate cost drivers for management of intracranial meningioma. METHODS: A single-center, retrospective cohort of patients undergoing microsurgery or radiosurgery of intracranial meningiomas from July 2011 to April 2017 was analyzed. Patient and tumor characteristics, subcategory costs, and potential cost drivers were analyzed within each treatment modality. RESULTS: Of 268 intracranial meningiomas, 198 were treated with microsurgery and 70 with stereotactic radiosurgery. Facility costs were the largest contributor to total costs for microsurgery (59.7%), whereas imaging costs were the largest contributor to stereotactic radiosurgery total costs (98.2%). Patients with non-skull base tumors had larger tumors (3.7 ± 1.9 cm vs. 2.7 ± 1.2 cm, P = 0.0001) and were more likely to undergo microsurgery (81.7% vs. 55.2%) than patients with skull base tumors. Univariate analysis suggested that American Society of Anesthesiologists status, length of stay, discharge disposition, and maximal tumor size impacted cost during microsurgery (P = 0.001), but only length of stay (P = 0.0001) and maximal tumor size (P = 0.01) were drivers of total costs on multivariate analysis. For radiosurgery, age significantly affected cost on univariate (P = 0.001) and multivariate (P = 0.003) analysis. CONCLUSIONS: Implementing protocols to reduce facility usage and imaging would mitigate total costs and improve resource utilization while maintaining high-quality patient care. Additional cost-effectiveness studies evaluating patients with true therapeutic equipoise will provide further guidance in these efforts.
引用
- Abou-Al-Shaar H, Azab MA, Karsy M, et al. Assessment of Costs in Open Microsurgery and Stereotactic Radiosurgery for Intracranial Meningiomas. World Neurosurg. 2018. PMID: 30064026. doi:10.1016/j.wneu.2018.07.161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。